Tech Center 1600 • Art Units: 1641 1644
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18765663 | Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody | Non-Final OA | Janssen Biotech, Inc. |
| 17422591 | COMPOSITIONS AND METHODS FOR MODULATING CELLULAR INTERNALIZATION | Final Rejection | The Regents of the University of California |
| 17625683 | COMPOSITIONS AND METHODS OF USING A HUMANIZED ANTI-DKK2 ANTIBODY | Final Rejection | YALE UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy